Characterization of monolithic matrix patch system containing tulobuterol

Archives of Pharmacal Research

Volumn 31, Issue 8, 2008, Pages 1029-1034

  Rhee, Yun Seok ^a   Kwon, Seok Young ^a   Park, Chun Woong ^a   Choi, Na Young ^a   Byun, Woo Jin ^a   Chi, Sang Cheol ^a   Park, Eun Seok ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Drug uptake; Monolithic patch; Permeation rate; Release rate; Transdermal; Tulobuterol

Indexed keywords

ADHESIVE AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE; EXCIPIENT; TERBUTALINE; TULOBUTEROL;

ANIMAL; ARTICLE; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INTRADERMAL DRUG ADMINISTRATION; MALE; PERMEABILITY; RAT; SKIN ABSORPTION; SPRAGUE DAWLEY RAT;

ADHESIVES; ADMINISTRATION, CUTANEOUS; ADRENERGIC BETA-AGONISTS; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EXCIPIENTS; MALE; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; SKIN ABSORPTION; TERBUTALINE;

EID: 51849118848     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-001-1264-8     Document Type: Article

References (27)

1. Barry, B. W., Dermatological Formulations. Marcel Dekker, New York, pp. 49-94 (1983).
2. B. W. Barry 2001 Novel mechanisms and devices to enable successful transdermal drug delivery Eur. J. Pharm. Sci. 14 101 114
3. N. Burioka M. Miyata M. Endo Y. Fukuoka H. Suyama H. Nakazaki K. Igawa E. Shimizu 2005 Alteration of the circadian rhythm in peak expiratory flow of nocturnal asthma following nighttime transdermal beta2-adrenoceptor agonist tulobuterol chronotherapy Chronobiol. Int. 22 383 390
4. M. Cazzola F. Imperatore A. Salzillo F. Di Perna F. Calderaro A. Imperatore M. G. Matera 1998 Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia Chest 114 411 415
5. P. Chedgzoy G. Winckle C. M. Heard 2002 Triclosan: release from transdermal adhesive formulations and in vitro permeation across human epidermal membranes Int. J. Pharm. 235 229 236
6. Y. J. Cho H. K. Choi 1998 Enhancement of percutaneous absorption of ketoprofen: effect of vehicles and adhesive matrix Int. J. Pharm. 169 95 104
7. Cleary, G. W., Transdermal Controlled Release Systems. In: Langer, R. S. and Wise, D. L. (Eds.), Medical applications of controlled release. CRC Press, Boca Raton, pp. 203-251 (1984).
8. M. Guyot F. Fawaz 2000 Design and in vitro evaluation of adhesive matrix for transdermal delivery of propranolol Int. J. Pharm. 204 171 182
9. T. Higuchi 1960 Physical chemical analysis of percutaneous absorption process from creams and ointments J. Soc. Cosmet. Chem. 11 85 97
10. W. I. Higuchi 1962 Analysis of data on the medication release from ointments J. Pharm. Sci. 51 802 804
11. T. Horiguchi R. Kondo J. Miyazaki K. Fukumokto H. Torigoe 2004 Clinical evaluation of a transdermal therapeutic system of the beta2-agonist tulobuterol in patients with mild or moderate persistent bronchial asthma Arzneimittelforsch. 54 280 285
12. C. W. Jeans C. M. Heard 1999 A therapeutic dose of primaquine can be delivered across excised human skin from simple transdermal patches Int. J. Pharm. 189 1 6
13. T. Kokubo K. Sugibayashi Y. Morimoto 1991 Diffusion of drug in acrylic-type pressure-sensitive adhesive matrices. I. Influence of physical property of the matrices on the drug diffusion J. Control. Release 17 69 78
14. T. Kokubo K. Sugibayashi Y. Morimoto 1994 Interaction between drugs and pressure-sensitive adhesives in transdermal therapeutic systems Pharm. Res. 11 104 107
15. B. J. Lipworth D. G. McDevitt 1992 Inhaled beta 2-adrenoceptor agonists in asthma: help or hindrance? Br. J. Clin. Pharmacol. 33 129 138
16. M. Miyajima A. Koshika J. Okada M. Ikeda 1999 Effect of polymer/basic drug interactions on the two-stage diffusion-controlled release from a poly(l-lactic acid) matrix J. Control. Release 61 295 304
17. Y. Morimoto T. Kokubo K. Sugibayashi 1992 Diffusion of drugs in acrylic-type pressure-sensitive adhesive matrix. II. Influence of interaction J. Control. Release 18 113 122
18. K. Moser K. Kriwet A. Naik Y.N. Kalia R.H. Guy 2001 Passive skin penetration enhancement and its quantification in vivo Eur. J. Pharm. Biopharm. 52 103 112
19. K. Musoh K. Kawamura I. Miyake S. Shimada T. Ohashi 1999 The effect of tulobuterol tape on histamine-induced bronchoconstriction in conscious guinea pigs: long duration of action Jpn. J. Pharmacol. 79 401 402
20. O. Nishiyama H. Taniguchi Y. Kondoh T. Kimura K. Kato H. Kume K. Shimokata 2006 Comparison of the effects of tulobuterol patch and salmeterol in moderate to severe asthma Clin. Exp. Pharmacol. Physiol. 33 1016 1021
21. K. R. Patel 1985 Tulobuterol in the management of obstructive airways disease in adults Clin. Ther. 7 452 467
22. Patel, K.R., Prolonged treatment with oral and inhaled tulobuterol does not induce airway tachyphylaxis. Lung, 168,Suppl 210-218 (1990).
23. S. D. Roy M. Gutierrez G. L. Flynn G. W. Cleary 1996 Controlled transdermal delivery of fentanyl: Characterizations of pressure sensitive adhesives for matrix patch design J. Pharm. Sci. 85 491 495
24. K. Sato N. Mitsui T. Hasegawa K. Sugibayashi Y. Morimoto 2001 Potential usefulness of solubility index for prediction of the skin permeation rate of 5-ISMN from pressure-sensitive adhesive tape J Control. Release 73 269 277
25. K. Schaffler P. W. Reeh 1987 Induction and reduction of muscle tremor upon acute and repeated administration of the beta 2-agonists terbutaline, salbutamol and tulobuterol Int. J. Clin. Pharmacol. Ther. Toxicol. 25 673 682
26. H. S. Tan W. R. Pfister 1999 Pressure-sensitive adhesives for transdermal drug delivery systems Pharm. Sci. Technol. Today 2 60 69
27. R. Toddywala Y. W. Chien 1990 Evaluation of silicone-based pressuresensitive adhesives for transdermal drug delivery. I. Effect of penetrant hydrophilicity J. Control. Release 14 29 41